- Chairman: Steven E Gross
- Managing Partner: R Max Crane
- Number of partners: : 63
- Number of other lawyers: 89
Sills Cummis & Gross P.C., a full-service corporate law firm,represents national and international clients. The firm’s work is diversified among industries such as pharmaceutical and medical device, banking and finance, healthcare, life sciences, retail and commercial real estate, manufacturing and technology. The firm is an Am Law 200 firm and has been selected as a ‘2011 Go To Law Firm ® for the Top 500 Companies’.
Main Areas of Practice:
Banking & Finance:
The group represents agents, senior lenders or other syndicate members, sellers or purchasers of a participation, as assignors or assignees of direct loan interests, or as parties to second lien and mezzanine transactions, sophisticated inter-creditor agreements, subordination and subordinated debt agreements. The group also has specialized expertise with litigation, bankruptcy, health care finance and real estate finance matters.
The group has broad experience in all aspects of bankruptcy, reorganization and creditors’ rights matters, including representing debtors, official and unofficial committees, secured and unsecured creditors, trustees and other parties in interest in out-of-court restructurings and in Chapter 11 reorganization cases. The group has also structured “pre-negotiated” plans of reorganization to expedite the Chapter 11 process and has extensive experience in representing creditors in Uniform Commercial Code lien enforcement issues.
Complex Litigation/Class Action Defense:
The firm has a broad spectrum of litigation expertise reflecting the diversity of its clients. The firm’s litigators regularly assist companies in cases involving commercial transactions, banking, healthcare, intellectual property, technology, construction, real estate, insurance, administrative law, antitrust, directors’ and officers’ liability, employment, unfair competition, securities, tax and business crimes.
The group serves clients at all stages of projects, including project delivery systems, contracts/project documentation/risk allocation, claims avoidance, delay/defect claims, financial structuring and restructuring, trial advocacy and surety claims/defense.
Corporate Internal Investigations & Business Crimes:
The firm counsels and, if necessary, aggressively defends clients who are the subjects of investigations alleging or involving: antitrust price-fixing, bank fraud, civil tax litigation, class and derivative actions, commercial bribery, consumer fraud, criminal environmental investigations, FDA related actions, government contracting fraud, healthcare fraud and abuse, insider trading and revenue recognition, pension fraud, securities fraud, tax fraud investigations and prosecutions, and whistleblower suits.
The firm has one of the largest corporate practices in New Jersey regularly advising both public and private companies. The firm’s attorneys regularly handle US and cross-border M&A matters; corporate, securities and regulatory compliance issues; and joint ventures. They also create and implement corporate governance and compliance programs.
Employment & Labor:
The group provides management side litigation defense, employment counseling and training, assistance with compliance and investigations, and traditional labor law representation. They also assist with employee benefit plans and related issues; and focus on retirement and pension plans, health and welfare plans and executive compensation.
The group represents health systems, hospitals, nursing homes, long-term care facilities, ambulatory surgery centers, home health companies, investment funds, imaging centers, medical groups, independent practice associations, management companies and other health care businesses. The group’s attorneys focus on transactions and corporate, finance, regulatory and compliance, government and internal investigations, labor and employment, real estate, litigation, bankruptcy and antitrust, among others.
The group specializes in many aspects of intellectual property law, including litigation, counseling, patents, trademarks, copyrights, licensing and transactions, Internet law, IP portfolio analysis and strategic planning, Clearance and Freedom to Operate analysis, alternative dispute resolution, acquisition risk management, trade secrets and unfair competition.
The firm is a major player in the life sciences industry, handling complex transactions on a national and international platform. The firm’s interdisciplinary team focuses on all aspects of these transactions, including corporate counseling; corporate governance and compliance; employment law; intellectual property; collaborations and joint ventures; licensing, development, supply and distribution arrangements; litigation; mergers and acquisitions; public and private financing; real estate; regulatory; research and development; strategic alliances; tax; and technology transfers.
The firm provides strategic legal advice on transactional matters including mergers, acquisitions and divestitures; capital raising; manufacturing and distribution; and licensing, collaboration and technology transfer issues. The firm’s vast litigation experience includes acting as national and local counsel in mass tort, class action and related products liability, warranty and infringement litigation; patent prosecution; business disputes; internal investigations and regulatory compliance matters.
Sills Cummis & Gross has earned a reputation as a “goto” firm to defend complex product liability cases and mass tort litigation. For the past four decades, the firm has successfully represented pharmaceutical, medical device, consumer product, industrial equipment and chemical companies as national, regional and New Jersey counsel in “bet the company” litigation.
The group specializes in investment, vertical and horizontal acquisition and disposition; condominiumizations; retail, office, industrial and warehouse leasing; and mixed- and single-use development/redevelopment and construction. Also embraced as additional expertise by the group are the areas of government relations, zoning and land use; and conventional and capital markets financing, including securitized and mezzanine financings.